Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity
Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity
复制标题
DOI:
10.1016/j.bbamcr.2010.01.005
复制
发表时间:
2010-03-01
影响因子:
5.1
通讯作者:
Lonning, Per Eystein
中科院分区:
文献类型:
--
作者:
Berge, Elisabet Ognedal;Staalesen, Vidar;Lonning, Per Eystein
While the majority of RNA transcripts from protein-encoding genes in the human genome are subject to physiological splicing, pathological splicing is increasingly reported in cancer tissue. Previously, we identified >90 different splice variants of Chk2, a gene encoding a serine/threonine kinase propagating the DNA damage signal by phosphorylating and activating several downstream substrates like p53. Cdc25A, and Cdc25C involved in cell cycle arrest and apoptosis. While alternative splice forms of other genes have been reported to exert a dominant-negative effect on the wild-type molecules, the function of Chk2 splice protein variants is still unclear. Here we evaluated the function of four Chk2 splice proteins for which mRNA splice variants were identified in human breast carcinomas. These splice variants were stably expressed as nuclear proteins. Two splice forms (Chk2 Delta 4 and Chk2del(2-3)) expressed kinase activity while variants Chk2 Delta 11 and Chk2isol were essentially kinase inactive. Independent of intrinsic kinase activity, each splice variant impaired wild-type Chk2 activity through heterodimerization. Based on our findings, we suggest alternative splicing as a possible novel mechanism for repression of the Chk2 wild-type function. (C) 2010 Elsevier B.V. All rights reserved.